Speaker

Home•Speakers•Dr Helen O’Neill

Dr Helen O’Neill

CEO + Founder Hertility Health

Dr Helen O’Neill is CEO and Founder of Hertility Health, an innovative health tech company that applies a precision medicine-based approach to reproductive health. She founded Hertility Health to enable women to make informed decisions about their fertility and gain insights into their reproductive and genetic health.

She has a tenured position at University College London where she lectures both masters and medical students in reproductive and molecular genetics. Dr O’Neill was awarded in the Top Twenty Women in Data, 2019.

 

AllSessions

Day I
June 1, 2022
3:15 pm

RoundTable: The Future of Fertility

The fertility journey is notoriously opaque and difficult to navigate. Medicine as a whole, however, is entering an era of personalization. In this roundtable we will explore in what ways personalized medicine holds the promise of revolutionize female fertility and gynecological diagnoses (31% of women will suffer from a reproductive health issue at some point in their lives). Featuring: Kindbody: a leading fertility and family-building benefits provider for employers offering comprehensive virtual and in-person care. Parla: a digital health platform putting data and knowledge in women’s hands, aiming to revolutionize and reframe the conversations around fertility and miscarriage. Hertility: At-home hormone and fertility testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause. With moderation focusing on how ovarian ageing can help us decipher long-term health by Staša Stanković.
Dr. Lynn Marie Westphal, MDStaša StankovićLina ChanDr Helen O’Neill
1 June
Time:  3:15 pm - 4:45 pm
Location:  The fertility journey is notoriously opaque and difficult to navigate. Medicine as a whole, however, is entering an era of personalization. In this roundtable we will explore in what ways personalized medicine holds the promise of revolutionize female fertility and gynecological diagnoses (31% of women will suffer from a reproductive health issue at some point in their lives). Featuring: Kindbody: a leading fertility and family-building benefits provider for employers offering comprehensive virtual and in-person care. Parla: a digital health platform putting data and knowledge in women’s hands, aiming to revolutionize and reframe the conversations around fertility and miscarriage. Hertility: At-home hormone and fertility testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause. With moderation focusing on how ovarian ageing can help us decipher long-term health by Staša Stanković.
Speaker:  Dr. Lynn Marie Westphal, MDStaša StankovićLina ChanDr Helen O’Neill